We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.


Cell Culture – News and Features

Bacteria in an intestine.

Novel Antibiotic Kills Pathogenic Bacteria but Spares Healthy Gut Microbes

Researchers have developed a new antibiotic that reduced or eliminated drug-resistant bacterial infections in mouse models of acute pneumonia and sepsis while sparing healthy microbes in the mouse gut.
Floating cells on an orange background.

Challenges and Solutions in Cell Therapy Development

In this article, we explore how researchers are tackling some of the challenges preventing cell therapies from being more widely used. We also outline advances in manufacturing and regulatory approval processes that will help expand patient access to life-changing treatments.
A futuristic-style illustration of a trophy on a dark blue background.
Industry Insight

SLAS Europe 2024 New Product Award: Top Contenders Announced

Finalists for the New Product Award at the SLAS Europe conference showcase cutting-edge innovations in life sciences, evaluated on technical merit, commercial feasibility, originality, impact and market opportunity. Here, we take a look at the six nominees and the products competing for this year’s award.
This digitally-colorized, negative-stained transmission electron microscopic (TEM) image depicted a number of Influenza A virions.

Drug-Like Molecule Shows Promise in Preventing Flu Infection

Scripps Research scientists have developed a potential drug-like molecule that blocks the first stage of type A influenza infection. The drug-like inhibitors block the virus from entering the body’s respiratory cells.
Cancer cells.

First-of-its-Kind Cancer Drug Shows Anti-Tumor Activity in Animal Models

Behind the scenes, as tumors progress and gain resistance to treatment, a protein called YB-1 quietly gives directions. Now, researchers have developed a first-of-its-kind drug that inhibits YB-1, effectively silencing those orders.
The newly developed multiplexed orthogonal base editors (MOBEs) minimize unwanted edits while still achieving high levels of efficiency.

Multiplexed Orthogonal Base Editors Install Multiple Point Mutations at Once

Researchers from the University of California San Diego have developed new, efficient genome editing tools called multiplexed orthogonal base editors (MOBEs) to install multiple point mutations at once
Cancer cells.

Mouse Study Explores Why Glioblastoma Treatment May Work Better in the Morning

Glioblastoma is an aggressive brain cancer that has no cure. A recent chart study of patients with glioblastoma found that taking chemotherapy in the morning was associated with a three- to six-month increase in median survival.
Two cell types circle an outline of a human body.

Germ Cell Development Insights Pave the Way for Future Infertility Treatments

By revealing the mechanisms behind epigenetic reprogramming and differentiation, researchers pave the way to new infertility treatments.
Two researchers in a lab.

Important Gene in the Fight Against Prostate Cancer Identified

A new study from Aarhus University finds that men with mutations in a particular gene are at greater risk of developing metastases after prostate cancer.
Cancer cells.

Thalidomide Derivatives Show Promise Against Resistant Cancer Cells

A study by Goethe University Frankfurt points to the possibility that thalidomide derivatives are potentially suitable for treating cancer.